• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VANTIVE US HEALTHCARE LLC PRISMAFLEX SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VANTIVE US HEALTHCARE LLC PRISMAFLEX SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 107640US
Medical Device Problem Code Air/Gas in Device (4062)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/29/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Prismaflex st150 set has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that an "air in line" event was observed during continuous renal replacement therapy with a prismaflex st150 set, described as "there were air bubbles at the start of pre-blood-pump (pbp) peristaltic pump roller and fluid was going to the roller and air bubbles when it exits the rollers".The set access line to the patient had "blood from the patient to the pbp line intersection but was all air after that to the safety clamp".There was no machine alarm noted.This occurred two (2) times with the same patient using two (2) different sets.Both sets were replaced to continue treatment without the extracorporeal blood being returned to the patient either time.There was no report of serious injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
Additional information: d9, h3, h6, h11.H11: the device was received for evaluation.Visual inspection of the actual sample showed the product to be blood filled and coagulated.Functional testing could not be performed.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The cause of the reported failure could not be determined.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX SET
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
VANTIVE US HEALTHCARE LLC
deerfield IL
Manufacturer (Section G)
VANTIVE HEALTHCARE - MEYZIEU
7, av. lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
510 lake cook rd
deerfield, il, IL 60015
8153072966
MDR Report Key24422381
Report Number8010182-2026-00174
Device Sequence Number10577308
Product Code KDI
UDI-Device Identifier00085412917696
UDI-Public00085412917696
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K212216
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Remedial Action Notification
Type of Report Initial,Followup
Report Date (Section B) 03/31/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number107640US
Device Lot Number25E0032CA
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/29/2026
Supplement Date Received by Manufacturer03/19/2026
Initial Report FDA Received Date02/23/2026
Supplement Report FDA Received Date03/31/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
8010182-12/17/25-001-C
Patient Sequence Number1
Patient SexUnknown
-
-